References
- Gilmer TP, O’Connor PJ, Manning WG, Rush WA. The cost to health plans of poor glycemic control. Diabetes Care 1997;20:1847–53
- American Diabetes Association. Economic costs of diabetes in the U.S. in 2002. Diabetes Care 2003;26:917–32
- Skyler JS, Oddo C. Diabetes trends in the USA. Diabetes Metab Res Rev 2002;18:S21–S26
- Vinik AI, Vinik E. Prevention of the complications of diabetes. Am J Manag Care 2003;9(Suppl):S63–S80
- American Diabetes Association. Clinical practice recommendations 1999. Diabetes Care 1999;22(Suppl 1):S1–S114
- Ulcickas Yood M, Elston Lafata J, Koro C, et al. Time to pharmacotherapy change in response to elevated HbA1c test results. J Gen Intern Med [in press]
- Saydah SH, Fradkin J, Cowie CC. Poor control of risk factors for vascular disease among adults with previously diagnosed diabetes. J Am Med Assoc 2004;291:335–42
- Koro CE, Bowlin SJ, Bourgeois N, Fedder DO. Glycemic control from 1988 to 2000 among U.S. adults diagnosed with type 2 diabetes: a preliminary report. Diabetes Care 2004;27: 17–20
- Wright A, Burden AC, Paisley RB, et al.; for the UK Prospective Diabetes Study Group. Sulfonylurea inadequacy: efficacy of addition of insulin in patients with type 2 diabetes in the UK Prospective Diabetes Study (UKPDS 57). Diabetes Care 2002;25: 330–6
- Snoek FJ. Breaking the barriers to optimal glycaemic control – what physicians need to know from patients’ perspectives. Int J Clin Pract Suppl 2002;129:80–4
- An analysis of insulin conversion patterns and treatment duration in enrollees with Type II diabetes. Eden Prairie (MN): Ingenix Pharmaceutical Services; 2002
- Mollema ED, Snoek FJ, Ader HJ, et al. Insulin-treated diabetes patients with fear of self-injecting or fear of self-testing: psychological comorbidity and general well-being. J Psychosom Res 2001;51: 665–72
- Mollema ED, Snoek FJ, Heine RJ, van der Ploeg HM. Phobia of self-injecting and self-testing in insulin-treated diabetes patients: opportunities for screening. Diabetic Med 2001;18:671–4
- Berlin I, Bisserbe JC, Eiber R, et al. Phobic symptoms, particularly the fear of blood and injury, are associated with poor glycemic control in type I diabetic adults. Diabetes Care 1997;20:176–8
- Zambanini A, Newson RB, Maisey M, Feher MD. Injection related anxiety in insulin-treated diabetes. Diabetes Res Clin Pract 1999;46:239–46
- Musey VC, Lee JK, Crawford R, et al. Diabetes in urban African-Americans. I. Cessation of insulin therapy is the major precipitat ing cause of diabetic ketoacidosis. Diabetes Care 1995;18:483–9
- Turner RC, Cull CA, Frighi V, et al. Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49) [UK Prospective Diabetes Study (UKPDS) Group]. J Am Med Assoc 281;21: 2005–12